Teva Pharmaceutical Industries (MEX:TEVA N) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 06, 2026)


MEX:TEVA N Teva Pharmaceutical Industries Ltd MEX:TEVA N
40 GF Score
Price MXN597.50
GF Value MXN347.38
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Teva Pharmaceutical Industries's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

MEX:TEVA N vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Margin of Safety % (DCF FCF Based) falls into.


MEX:TEVA N
40GF Score
Teva Pharmaceutical Industries Ltd MEX:TEVA N
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Teva Pharmaceutical Industries (MEX:TEVA N) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of MXN597.50 is trading 72% above its estimated GF Value™ of MXN347.38. GuruFocus considers Teva Pharmaceutical Industries to be Significantly Overvalued.

Key valuation signals for MEX:TEVA N:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: MXN347.38 vs. price of MXN597.50 (72% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the MEX:TEVA N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
40GF Score

Get the complete analysis for MEX:TEVA N

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN597.50
Price
MXN347.38
GF Value